Januvia and Byetta Linked to Pancreatitis

The FDA noted last week that Januvia, Merck & Co.’s diabetes drug, may be linked to cases of acute pancreatitis. The federal agency said there had been 88 cases of acute pancreatitis reported in those taking Januvia between October 2006 and February 2009. In 2008, Amylin Pharmaceuticals Inc.’s Byetta had also been linked to acute pancreatitis.
Acute pancreatitis is a serious disorder that can lead to an increase in mortality. Currently, there are 110 Byetta lawsuits pending in US courts.